—

Hinge Health, Inc. (HNGE) — the peer cohort

As of 2026-11-02 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.

Hinge Health, Inc. ranks 7 of 8 in its cohort on the Closelooknet composite (56/100) — the cohort is led by Halozyme Therapeutics Inc at 73/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
HNGE Hinge Health, Inc. 56 98 63 21 ok 2.8%
HQY HealthEquity Inc 62 77 70 40 ok 3.7%
VEEV Veeva Systems Inc Class A 61 96 75 27 bull 4%
TEM Tempus AI, Inc. Class A Common Stock 41 83 19 16 bear 30.8%
HALO Halozyme Therapeutics Inc 73 97 94 38 ok 3.8%
DXCM DexCom Inc 66 78 80 38 watch 11.1%
ONC BeiGene, Ltd. 64 83 64 30 info 7%
ARGX argenx NV ADR 63 68 74 29 info 18.4%

Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-11-02

Quick answers

Who are Hinge Health, Inc.'s peers in the Closelooknet universe?

The cohort is drawn from shared Closelooknet index membership first, then sector: HealthEquity Inc (HQY), Veeva Systems Inc Class A (VEEV), Tempus AI, Inc. Class A Common Stock (TEM), Halozyme Therapeutics Inc (HALO), DexCom Inc (DXCM), BeiGene, Ltd. (ONC), argenx NV ADR (ARGX), as of 2026-11-02.

How does HNGE score against its peers?

Hinge Health, Inc.'s composite reads 56/100, ranking 7 of 8 in its cohort as of 2026-11-02; the cohort's highest composite is Halozyme Therapeutics Inc at 73/100. Closelooknet scores are research diary readings, not ratings or advice.

Related in the Closelooknet universe

then Health Information Services, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.